Clinical Trial Update: Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

View source ↗

Summary

A completed non-interventional registry study evaluating the effectiveness of TheraSphere for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Hepatocellular Carcinoma | Status: COMPLETED